They found 31 varieties of medicines, including higher-generation antibiotics like Cefixime, Cefpodoxime, Ofloxacin, ...

Sulopenem was superior to amoxicillin/clavulanate and ciprofloxacin in treating antimicrobial resistant uncomplicated urinary tract infections. The antibiotic was ...

FDA approved Orlynvah for the Tx of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.

Alternative for treatment failure: parenteral therapy (home or hospital); sputum culture-based or adjusted therapy; consider referral to specialist Group III (suppurative CB) First-line oral ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

As assessed by Future Market Insights, among the drug type, quinolones held a market share of around 37.6% in the global market, in 2022. In 2022, the catheter associated urinary tract infections ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

This unit is a significant milestone in reducing India’s dependence on countries like China and Korea for APIs, as it will meet around 60 per cent of the domestic demand for potassium clavulanate API, ...

The Central Drug Regulatory Authority has found samples of four drugs, including widely used calcium supplement Shelcal 500 and Pan D, as spurious, while samples of 49 drugs were listed as not of ...

Ltd., Amoxicillin And Potassium Clavulanate Tablets by Alkem Health, Ciprofloxacin Tablets by Cadila Pharmaceuticals Limited and many more were identified as Not of Standard Quality (NSQ ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem.